mefloquine has been researched along with Disease Models, Animal in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.64) | 18.7374 |
1990's | 3 (5.45) | 18.2507 |
2000's | 13 (23.64) | 29.6817 |
2010's | 31 (56.36) | 24.3611 |
2020's | 6 (10.91) | 2.80 |
Authors | Studies |
---|---|
Bacher, A; Behrendt, C; Brücher, K; Fischer, M; Gräwert, T; Held, J; Illarionov, B; Konzuch, S; Kurz, T; Lienau, C; Maes, L; Mordmüller, B; Wittlin, S | 1 |
Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
Angulo-Barturen, I; Antonova-Koch, Y; Bashyam, S; Birkholtz, LM; Botha, ME; Charman, SA; Chibale, K; Ferrer, S; Gonzàlez Cabrera, D; Han, Z; Jiménez-Díaz, MB; Lawrence, N; Le Manach, C; Martínez, MS; Meister, S; Nchinda, AT; Nondaba, SH; Paquet, T; Reader, J; Street, LJ; Taylor, D; Waterson, D; White, KL; Winzeler, EA; Wittlin, S; Witty, MJ; Younis, Y; Zabiulla, M | 1 |
Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
Carlier, PR; Ding, S; Fike, KR; Klemba, M | 1 |
Boroujeni, SS; Dehpour, AR; Jafari, RM; Karimi, E; Maleki, A; Mohammadi, P; Sabzevari, O; Shafaroodi, H; Solaimanian, S | 1 |
Santhakumar, V; Shao, M; Yu, H; Yu, J | 1 |
Bhatia, SN; Grilo Ruivo, MT; Lemos Rocha, LF; Mancio-Silva, L; Marques, S; Mota, MM; Vera, IM | 1 |
Hemphill, A; Lundström-Stadelmann, B; Rufener, R | 1 |
Carvalho, LJM; Nugraha, AB; Sivakumar, T; Tuvshintulga, B; Yokoyama, N | 1 |
Amer, BS; El-Ebiary, AA; Elkaliny, HH; Elmehy, DA; Gamea, GA; Ismail, HIH; Soliman, NA | 1 |
Chen, Z; Shen, X; Wu, H; Zhang, M | 1 |
Gong, LL; Li, YH; Lin, RX; Wu, JC; Yang, SL; Zhang, GF | 1 |
Blauwblomme, T; Capelle, L; Chever, O; Couillin, I; Dossi, E; Guinard, E; Huberfeld, G; Le Bert, M; Moulard, J; Pallud, J; Rouach, N; Vasile, F | 1 |
Akter, J; Aogo, RA; Cromer, D; Davenport, MP; Elliott, T; Fogg, LG; Haque, A; Khoury, DS; Laohamonthonkul, P; Liligeto, UN; Nair, AS; Pernold, CPS; Romanczuk, AS; Soon, MSF; Thomas, BS | 1 |
Amnuaysirikul, J; Caridha, D; Gao, X; Grogl, M; Hickman, M; Ishida, H; Li, Q; Magill, AJ; O'Neil, MT; Ohrt, C; Ray, P; Weina, PJ; Zhang, P | 1 |
Ballesteros-Zebadúa, P; Franco-Pérez, J; Manjarrez-Marmolejo, J | 1 |
Hemphill, A; Küster, T; Müller, J; Risch, C; Rufener, R; Stadelmann, B | 1 |
Cahill, ME; Christoffel, DJ; Golden, SA; Heshmati, M; Khibnik, LA; Pfau, ML; Russo, SJ; Seeley, EL | 1 |
Chen, ZY; Jiang, L; Liu, S; Shen, FY; Shen, XL; Wang, YW; Wang, ZR; Zhao, X; Zhong, W | 1 |
Kamel, RO | 1 |
Angulo-Barturen, I; Baker, M; Duparc, S; Elliott, S; Ferrer, S; Griffin, P; Hooft van Huijsduijnen, R; Jiménez-Díaz, MB; Leroy, D; Marquart, L; Martínez, MS; McCarthy, JS; Möhrle, JJ; O'Rourke, P; Rockett, R; Sekuloski, S; Sloots, T; Trenholme, K; Wells, TN | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Abbadi, BL; Basso, LA; Campos, MM; de Souza, MV; Gonçalves, RS; González-Martín, J; López-Gavín, A; Rodrigues-Junior, VS; Santos, DS; Trindade, RV; Tudó, G; Villela, AD | 1 |
Gorgas, D; Hemphill, A; Lundström-Stadelmann, B; Marreros, N; Rufener, R | 1 |
Jiao, PY; Mei, JY; Xiao, SH | 2 |
Xiao, SH; Zhang, CW | 2 |
Li-li, X; Qiang, HQ; Xiao, SH; Xue, J; Zhang, YN | 1 |
Hemphill, A; Hermann, C; Keiser, J; Küster, T; Scholl, S; Stadelmann, B | 1 |
Keiser, J; Manneck, T; Vargas, M | 1 |
Du, XL; Sun, J; Xiao, SH; Xue, J; Zhang, HB | 1 |
Cozens, S; Dow, GS; Gettayacamin, M; Hansukjariya, P; Imerbsin, R; Kenworthy, D; Komcharoen, S; Kyle, D; Milhous, W; Miller, A; Ohrt, C; Sattabongkot, J; Veazey, J | 1 |
Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
el-Din, SH; el-Lakkany, NM; Hammam, OA; Sabra, AN | 1 |
Sun, J; Xiao, SH; Xue, J | 1 |
Amalvict, R; Baret, E; Briolant, S; Dormoi, J; Mosnier, J; Pradines, B; Rogier, C; Savini, H; Soulard, R; Souraud, JB | 1 |
Agrawal, R; Dutta, GP; Jain, SK; Shukla, OP; Tekwani, BL; Tripathi, R | 1 |
Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS | 1 |
Peters, W; Robinson, BL; Stewart, LB | 1 |
Benwell, K; Cliffe, IA; Dourish, CT; Gillespie, RJ; Knight, AR; Lerpiniere, J; Misra, A; Pratt, RM; Revell, D; Upton, R; Weiss, SM | 1 |
Amabeoku, GJ; Farmer, CC | 1 |
Carmona-Fonseca, J; Guzmán, V | 1 |
Handforth, A; Martin, FC | 1 |
Barnwell, JW; Bounngaseng, A; Collins, WE; Galland, GG; Grady, KK; Hall, P; Huber, C; Nace, D; Ruebush, TK; Sullivan, JJ; Sullivan, JS; Williams, A; Williams, T | 1 |
Gozalo, AS; Hall, BT; Lucas, CM; Magill, AJ; Qin, J | 1 |
Peters, W | 1 |
Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
Collins, WE; Galland, GG; Kaslow, DC; Lal, AA; Morris, CL; Saekhou, AM; Sullivan, JS; Xiao, L; Yang, C | 1 |
Collins, WE; Fryauff, DJ; Galland, GG; Jennings, V; Kendall, J; Morris, CL; Sullivan, JS | 1 |
Bermudez, LE; Young, LS | 1 |
Cravo, P; Culleton, R; Hunt, P; Mackinnon, MJ; Walliker, D | 1 |
Onabanjo, AO; Otigbuo, IN | 1 |
Armstead, A; Campbell, CC; Collins, WE; Milhous, WK; Roberts, JM | 1 |
3 review(s) available for mefloquine and Disease Models, Animal
Article | Year |
---|---|
[Cytochrome P-450 and the response to antimalarial drugs].
Topics: Administration, Oral; Adult; Amodiaquine; Animals; Antimalarials; Biotransformation; Child; Chloroquine; Cytochrome P-450 Enzyme System; Databases as Topic; Disease Models, Animal; Genotype; Humans; Malaria; Malaria, Falciparum; Mefloquine; Mice; Murinae; Mutation; Nutritional Status; Phenotype; Plasmodium berghei; Polymorphism, Genetic; Proguanil; Rats | 2006 |
New answers through chemotherapy?
Topics: Aminoquinolines; Animals; Antimalarials; Chemical Phenomena; Chemistry; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Humans; Liver; Malaria; Mefloquine; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Primaquine; Proguanil; Quinine; Quinolines; Research; Sesquiterpenes; Species Specificity; World Health Organization | 1984 |
Perspective on animal models: chronic intracellular infections.
Topics: Animals; Antitubercular Agents; Chronic Disease; Disease Models, Animal; Humans; Mefloquine; Mice; Mice, Inbred C57BL; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Predictive Value of Tests | 2001 |
1 trial(s) available for mefloquine and Disease Models, Animal
Article | Year |
---|---|
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development.
Topics: Adult; Animals; Antimalarials; Cohort Studies; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Erythrocytes; Female; Healthy Volunteers; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Plasmodium falciparum | 2016 |
51 other study(ies) available for mefloquine and Disease Models, Animal
Article | Year |
---|---|
Prodrugs of reverse fosmidomycin analogues.
Topics: Animals; Antimalarials; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Fosfomycin; HeLa Cells; Humans; Malaria; Mice; Mice, SCID; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Prodrugs; Structure-Activity Relationship | 2015 |
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
Topics: Animals; Antimalarials; Disease Models, Animal; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Mice; Mice, SCID; Microsomes, Liver; Molecular Structure; Parasitic Diseases, Animal; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyrazines; Solubility; Structure-Activity Relationship; Water | 2016 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
In vitro and in vivo evaluation of the antimalarial MMV665831 and structural analogs.
Topics: Animals; Antimalarials; Disease Models, Animal; Malaria; Mannich Bases; Mice; Plasmodium berghei; Plasmodium falciparum | 2020 |
Opioidergic and nitrergic systems mediate the anticonvulsant effect of mefloquine and chloroquine on seizures induced by pentylenetetrazol and maximal electroshock in mice.
Topics: Animals; Anticonvulsants; Chloroquine; Disease Models, Animal; Electroshock; Mefloquine; Mice; Naltrexone; Nitrites; Pentylenetetrazole; Seizures | 2022 |
Antiepileptogenic and neuroprotective effect of mefloquine after experimental status epilepticus.
Topics: Animals; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Mefloquine; Neuroprotective Agents; Pilocarpine; Rats; Seizures; Status Epilepticus | 2023 |
Targeting liver stage malaria with metformin.
Topics: Animals; Antimalarials; Cells, Cultured; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Hepatocytes; Humans; Inhibitory Concentration 50; Liver; Malaria; Male; Mefloquine; Metformin; Mice; Parasite Load; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Primaquine; Primary Cell Culture | 2019 |
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Topics: Albendazole; Animals; Anticestodal Agents; Antimalarials; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Echinococcosis; Echinococcus multilocularis; Ferritins; Humans; Mefloquine; Mice | 2020 |
Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo.
Topics: Aminoquinolines; Animals; Antimalarials; Artesunate; Babesia bovis; Babesia microti; Babesiosis; Disease Models, Animal; Drug Combinations; In Vitro Techniques; Lumefantrine; Mefloquine; Methylene Blue; Mice; Mice, Inbred BALB C | 2020 |
Oxidative stress mediated apoptotic potential of mefloquine on experimental trichinellosis.
Topics: Albendazole; Animals; Anthelmintics; Apoptosis; Disease Models, Animal; Jejunum; Larva; Male; Mefloquine; Mice; Muscles; Oxidative Stress; Reactive Oxygen Species; Trichinella spiralis; Trichinellosis | 2021 |
Membrane potential synchrony of neurons in anterior cingulate cortex plays a pivotal role in generation of neuropathic pain.
Topics: Action Potentials; Analgesics; Animals; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; Gyrus Cinguli; Mefloquine; Membrane Potentials; Neuralgia; Neurons; Rats, Sprague-Dawley | 2018 |
Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer.
Topics: AC133 Antigen; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cyclin D1; Disease Models, Animal; Drug Combinations; Hep G2 Cells; Humans; Lithium Chloride; Liver Neoplasms; Male; Mefloquine; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Transplantation, Heterologous | 2018 |
Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy.
Topics: Adenosine Triphosphate; Animals; Brain; Cerebral Cortex; Connexins; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Humans; Kainic Acid; Mefloquine; Mice; Nerve Tissue Proteins; Probenecid; Seizures; Signal Transduction | 2018 |
Quantification of host-mediated parasite clearance during blood-stage Plasmodium infection and anti-malarial drug treatment in mice.
Topics: Animals; Antimalarials; Artesunate; Blood; Disease Models, Animal; Fluorescence; Malaria; Mefloquine; Mice; Models, Theoretical; Organisms, Genetically Modified; Parasite Load; Parasitemia; Plasmodium berghei; Staining and Labeling | 2018 |
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
Topics: Acute Disease; Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Genotype; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Haptoglobins; Hemolytic Agents; Male; Mefloquine; Mice; Phenotype; Primaquine; Reticulocyte Count | 2013 |
Anticonvulsant effects of mefloquine on generalized tonic-clonic seizures induced by two acute models in rats.
Topics: Acute Disease; Animals; Anticonvulsants; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Electrodes, Implanted; Electroencephalography; Electroshock; Hindlimb; Male; Mefloquine; Pentylenetetrazole; Random Allocation; Rats; Rats, Wistar; Seizures; Survival Analysis | 2015 |
Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.
Topics: Administration, Oral; Animals; Anthelmintics; Antimalarials; Caco-2 Cells; Chromatography, Affinity; Chromatography, Liquid; Cystatins; Disease Models, Animal; Drug Repositioning; Echinococcosis; Echinococcus multilocularis; Electrophoresis, Polyacrylamide Gel; Female; Ferritins; Humans; Mefloquine; Mice, Inbred BALB C; Protein Binding; Tandem Mass Spectrometry; Treatment Outcome | 2015 |
Mefloquine in the nucleus accumbens promotes social avoidance and anxiety-like behavior in mice.
Topics: Action Potentials; Analysis of Variance; Animals; Anxiety; Disease Models, Animal; Dose-Response Relationship, Drug; Interpersonal Relations; Male; Maze Learning; Mefloquine; Mice; Mice, Inbred C57BL; Neurons; Nucleus Accumbens; Patch-Clamp Techniques; Stress, Psychological | 2016 |
Attenuation of Neuropathic Pain by Inhibiting Electrical Synapses in the Anterior Cingulate Cortex.
Topics: Animals; Connexins; Disease Models, Animal; Electrical Synapses; Gap Junction delta-2 Protein; Gyrus Cinguli; Mefloquine; Neuralgia; Neuronal Plasticity; Neurons; Rats; Synaptic Transmission | 2016 |
Interactions between mefloquine and the anti-fibrotic drug silymarin on Schistosoma mansoni infections in mice.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Disease Models, Animal; Drug Interactions; Enzymes; Fibrosis; Granuloma; Inflammation; Liver Function Tests; Male; Mefloquine; Mice; Parasite Load; Schistosomiasis mansoni; Silymarin; Treatment Outcome | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection.
Topics: Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Interactions; Drug Repositioning; Male; Mefloquine; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Tuberculosis, Multidrug-Resistant | 2016 |
To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis.
Topics: Albendazole; Animals; Anticestodal Agents; Disease Models, Animal; Echinococcosis; Echinococcus multilocularis; Female; Magnetic Resonance Imaging; Mefloquine; Mice; Mice, Inbred BALB C; Parasite Load; Ultrasonography | 2017 |
Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Anthelmintics; Cricetinae; Disease Models, Animal; Female; Hepatic Veins; Male; Mefloquine; Mesenteric Veins; Mice; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica; Treatment Outcome | 2009 |
Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose.
Topics: Administration, Oral; Animal Structures; Animals; Anthelmintics; Disease Models, Animal; Female; Histocytochemistry; Liver; Male; Mefloquine; Mice; Schistosoma japonicum; Schistosomiasis japonica; Time Factors | 2010 |
Effectiveness of mefloquine against Clonorchis sinensis in rats and Paragonimus westermani in dogs.
Topics: Animals; Anthelmintics; Clonorchiasis; Clonorchis sinensis; Disease Models, Animal; Dog Diseases; Dogs; Mefloquine; Paragonimiasis; Paragonimus westermani; Rats; Rodent Diseases; Survival Analysis; Treatment Outcome | 2010 |
Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.
Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mefloquine; Mice; Mice, Inbred Strains; Parasitic Diseases, Animal; Parasitic Sensitivity Tests; Praziquantel; Schistosoma japonicum; Schistosomiasis japonica; Schistosomicides; Treatment Outcome | 2011 |
In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Topics: Albendazole; Animals; Antiparasitic Agents; Disease Models, Animal; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Female; Humans; Mefloquine; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Parasitic Sensitivity Tests; Treatment Outcome | 2011 |
Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
Topics: Administration, Oral; Animals; Anthelmintics; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mefloquine; Mice; Praziquantel; Rodent Diseases; Schistosoma mansoni; Schistosomiasis mansoni; Treatment Outcome | 2011 |
Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration.
Topics: Administration, Oral; Animal Structures; Animals; Anthelmintics; Disease Models, Animal; Female; Mefloquine; Mice; Microscopy, Electron, Transmission; Organelles; Schistosoma japonicum; Schistosomiasis japonica | 2012 |
Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta).
Topics: Aminoquinolines; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Macaca mulatta; Malaria; Male; Mass Spectrometry; Mefloquine; Plasma; Plasmodium cynomolgi; Primate Diseases; Quinine; Treatment Outcome | 2011 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Granuloma; Liver; Male; Mefloquine; Mice; Parasite Egg Count; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2011 |
Histopathological changes of juvenile Schistosoma japonicum harbored in mice treated orally with mefloquine at a smaller single dose.
Topics: Animal Structures; Animals; Anthelmintics; Disease Models, Animal; Female; Liver; Mefloquine; Mice; Microscopy; Schistosoma japonicum; Schistosomiasis japonica; Survival Analysis; Time Factors | 2012 |
Confocal laser scanning microscopic observation on adult Schistosoma japonicum harbored in mice following treatment with single-dose mefloquine.
Topics: Administration, Oral; Animal Structures; Animals; Anthelmintics; Disease Models, Animal; Female; Liver; Male; Mefloquine; Mesenteric Veins; Mice; Microscopy, Confocal; Schistosoma japonicum; Schistosomiasis japonica | 2012 |
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.
Topics: Animals; Antimalarials; Apoptosis; Atorvastatin; Brain; Disease Models, Animal; Drug Therapy, Combination; Female; Heptanoic Acids; Histocytochemistry; Immunohistochemistry; Malaria, Cerebral; Mefloquine; Mice; Neurons; Plasmodium berghei; Pyrroles; Survival Analysis; Treatment Outcome | 2012 |
Haem polymerase as a novel target of antimalarial action of cyproheptadine.
Topics: Animals; Antimalarials; Chloroquine; Cyproheptadine; Disease Models, Animal; Drug Resistance; Enzyme Inhibitors; Hemeproteins; Mefloquine; Mice; Plasmodium yoelii; Quinine; Transferases; Treatment Outcome | 2002 |
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines | 2003 |
The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines.
Topics: Aminoquinolines; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Mice; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Primaquine; Time Factors | 2003 |
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Binding, Competitive; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Ligands; Mefloquine; Mice; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Phenethylamines; Purines; Pyrimidines; Radioligand Assay; Rats; Triazines; Triazoles | 2003 |
Gamma-aminobutyric acid and mefloquine-induced seizures in mice.
Topics: Acetanilides; Aminooxyacetic Acid; Animals; Anti-Anxiety Agents; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mefloquine; Mice; Seizures | 2005 |
Carbenoxolone and mefloquine suppress tremor in the harmaline mouse model of essential tremor.
Topics: 1-Octanol; Animals; Carbenoxolone; Central Nervous System Stimulants; Cerebellum; Chloroquine; Connexins; Disease Models, Animal; Dose-Response Relationship, Drug; Essential Tremor; Female; Gap Junction delta-2 Protein; Gap Junctions; Glycyrrhizic Acid; Harmaline; Heptanol; Injections, Subcutaneous; Mefloquine; Mice; Mice, Inbred ICR; Olivary Nucleus | 2006 |
Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.
Topics: Animals; Antimalarials; Aotidae; Chloroquine; Cytochromes b; Dihydropteroate Synthase; Disease Models, Animal; DNA, Protozoan; Drug Resistance, Multiple; Humans; Malaria, Falciparum; Mefloquine; Monkey Diseases; Parasitemia; Peru; Plasmodium falciparum; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase | 2007 |
Anemia and antibodies to the 19-kDa fragment of MSP1 during Plasmodium falciparum infection in Aotus monkeys.
Topics: Anemia; Animals; Antibodies, Protozoan; Antimalarials; Aotidae; Disease Models, Animal; Erythrocytes; Malaria, Falciparum; Mefloquine; Merozoite Surface Protein 1; Monkey Diseases; Parasitemia; Plasmodium falciparum | 2007 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys.
Topics: Adjuvants, Immunologic; Animals; Antimalarials; Disease Models, Animal; Female; Immunization; Malaria Vaccines; Malaria, Vivax; Male; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy; Vaccines, Synthetic | 1999 |
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys.
Topics: Adaptation, Physiological; Adult; Amodiaquine; Animals; Antimalarials; Aotidae; Child; Chloroquine; Disease Models, Animal; Drug Resistance; Female; Humans; Indonesia; Malaria, Vivax; Male; Mefloquine; Parasitemia; Plasmodium vivax; Saimiri; Splenectomy | 2000 |
Antimalarial drugs clear resistant parasites from partially immune hosts.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Resistance; Immunization; Malaria; Mefloquine; Mice; Plasmodium chabaudi | 2001 |
The in vitro and in vivo effects of mefloquine on Trypanosoma brucei brucei.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Drug Administration Schedule; Kidney; Male; Mefloquine; Mice; Trypanosoma brucei brucei; Trypanosomiasis, African | 1992 |
Adaptation of the Indochina I/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus).
Topics: Animals; Aotus trivirgatus; Cebidae; Chloroquine; Disease Models, Animal; Drug Resistance; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Saimiri; Splenectomy; Sulfadoxine | 1986 |